Vivia is formed by a team of outstanding professionals from Spain and other countries all over the world, confirming the Company’s potential and demonstrating our commitment to talent as the main business driver.
We have integrated an experienced multidisciplinary team trained at leading research centers, that enables us to give an efficient answer to the challenges presented by our targeted diseases.
Chairman & CSO
Joan Ballesteros is a bachelor in Chemical Sciences from the University of Barcelona and a doctor in Biomedicine from the Mount Sinai School of Medicine of the University of New York, USA. He has published more than 40 articles in journals of international prestige and is known worldwide for his work in pharmacology, applications of flow cytometry in the evaluation of drugs and computational models of drug activity.
Joan is a Founding Partner and Chief Scientific Officer of the company Novasite Pharmaceuticals in San Diego, California, a company that developed the basis of the ExviTech technological platform under his leadership and management. Joan headed Novasite for more than five years, and obtained more than $14M in NIH grants and more than $20M in total funding.
Chief Executive Officer
Spanish and American lawyer, he is a member of the New York Bar Association and MBA by Instituto de Empresa Business School. Ballesteros is founding partner and Vivia Biotech’s CEO, and a member of the Board of Directors at ASEBIO, the Spanish Association of Biotechnology Companies.
Andrés worked as finance and corporate lawyer in New York at Hunton & Williams LLP, and was the firm’s representative before the Spanish Chamber of Commerce. Previously Andres was part of the Legal Department and of the Latin-American Structured Finance Group at Bank Santander in New York. Andrés is an International MBA from Instituto de Empresa (Madrid), and Master (LLM) in Bank, Corporate and Financial Law BY Fordham University School of Law, New York.
Graduated in Medicine in 1991 from the University of Granada (Spain), Joaquin is a specialist in Hematology and PhD with honors from the Universidad Complutense de Madrid (Spain) in 2002. Joaquín is Head of the Hematology Department at the University Hospital 12 de Octubre in Madrid, sharing clinical and research tasks. His clinical work takes place mainly in the areas of multiple myeloma and myeloproliferative neoplasms, a field in which is an internationally recognized expert. He is also the head of the laboratory of molecular biology that is national and international benchmark. Joaquin leads the group of translational research and early clinical trials unit in hematology at the Hospital 12 de Octubre. Joaquín is in multiple research projects and clinical trials of national and international agencies, which resulted into 83 articles in international journals and more than 40 book chapters, as well as interventions in national and international conferences.
Joaquin is Vivia Biotech Medical Director since January 2013, constituting ever since a key piece of our team for the successful development of personalized medicine tests for the treatment of Hematological Malignancies.
His interest in the disadvantaged has led him to participate in several cooperation projects, including the development of a laboratory in Northern Ghana. Currently Joaquin plays a relevant role as Scientific Director of the CRIS Foundation Against Cancer.
SVP of Science
Graduated in Pharmacy and holds a PhD in Hematological Malignancies from the University of Salamanca (Spain), which she obtained at the laboratory of renowned flow cytometry expert Dr. Alberto Orfao.
Pilar is a professional scientist with more than fifteen years of experience in flow cytometry. Pilar is responsible for leading the laboratory and scientific activities of the company, from profiling and biomarker discovery programs, to product development of our personalized medicine tests.
Chief Financial Officer
Sergio Perez has a degree in business administration from the University of Alcalá de Henares and a Master in Financial Management from ESADE.
Sergio has over eight years of experience in the pharmaceutical industry having worked for, among others, the generics pharmaceuticals group Chemo and Cellerix biotech company. At Vivia he currently holds the position of CFO.
SVP Strategic Operations, Vivia Biotech-US
Of North American nationality, she obtained her degree in Biomedical Sciences from the University of New México, in Albuquerque, USA in a renowned group for flow cytometry automation.
Dr. Bennett has more than 5 years of experience in developing and operating the ExviTech Technological Platform, being responsible for the day to day functioning of Vivia ‘s research equipment with this platform.